SLP

Simulations Plus Inc.

Price

$18.33

return (12m)

38.55%

p/e

45.17

p/bv

2.64

DIVIDEND YIELD

0.00%

SLP price

Simulations Plus

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SLP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.71%

3 months

25.46%

1 year

38.55%

2 years

-53.76%

5 years

-60.44%

10 years

146.75%

Fundamentals SLP

Valuation

P/E

45.17

Sector -2.23

Industry 0.52

P/BV

2.64

Sector 2.14

Industry 2.30

P/Revenue (PSR)

4.47

Sector 1.98

Industry 2.36

EV/EBITDA

53.97

Sector -24.41

Industry -19.03

EV/EBIT

70.40

Sector -37.37

Industry -19.09

P/EBITDA

21.43

Sector -0.01

Industry 1.16

P/EBIT

31.90

Sector -2.00

Industry -0.30

P/Total Assets

2.40

Sector 1.15

Industry 1.24

P/Ativo Circ. Liq.

6.00

Sector -10.54

Industry -12.34

P/Cap.Giro

5.96

Sector 0.02

Industry 3.10

EPS

0.41

Sector -0.94

Industry -0.75

BVPS

6.95

Sector 3.93

Industry 4.90

Efficiency

Gross Margin

63.37%

Sector 44.21%

Industry 49.44%

EBITDA Margin

26.82%

Sector -312.85%

Industry -51.49%

EBIT Margin

20.56%

Sector -193.57%

Industry -51.11%

Operating Margin

14.01%

Sector -25.72%

Industry -28.72%

Net Profit Margins

9.90%

Sector -30.17%

Industry -32.17%

Giro Ativos

0.14

Sector 0.12

Industry 0.14

Profitability

ROE

5.84%

Sector -35.35%

Industry -37.91%

ROA

5.31%

Sector -29.04%

Industry -27.45%

ROIC

13.25%

Sector -439.00%

Industry -96.96%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

5.54

Sector 1.87

Industry 1.94

Dívida Líquida/EBITDA

-8.52

Sector -1.64

Industry -4.72

Dívida Líquida/EBIT

-11.11

Sector -0.81

Industry -1.84

Dívida Líquida/Patrimônio

-0.36

Sector -0.35

Industry -0.28

Dívida Bruta/Patrimônio

0.00

Sector 0.17

Industry 0.20

Equity/Assets

0.91

Sector 0.42

Industry 0.45

Liabilities/Assets

0.09

Sector 0.46

Industry 0.51

Growth

5Y Revenue CAGR

11.23%

Sector -

Industry -

5Y Earnings CAGR

-4.70%

Sector -

Industry -

FAIR VALUE OF Simulations Plus ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$18.33

Fair Value

$8.01

Upside Return potential.

-56.32%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals SLP

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
SLP	45.17	2.64	5.84%	0.00%	$366.80 M	9.90%
LLY	42.55	34.48	81.02%	0.54%	$1.08 T	34.99%
ISRG	38.26	6.56	17.15%	0.00%	$120.09 B	28.45%
SNY	7.10	1.26	17.79%	4.07%	$105.96 B	14.75%
NVS	23.21	7.06	30.41%	2.00%	$296.12 B	22.50%
TMO	29.78	3.93	13.19%	0.32%	$207.50 B	15.04%
ABT	25.64	3.09	12.06%	0.00%	$160.92 B	13.91%
MDT	22.18	2.13	9.59%	3.43%	$106.51 B	13.20%
GSK	13.15	4.44	33.77%	3.42%	$103.21 B	17.79%
CVS	46.73	1.76	3.78%	2.47%	$137.02 B	0.72%
BSX	18.64	2.57	13.78%	0.00%	$66.45 B	17.29%
TMDX	13.95	4.86	34.80%	0.00%	$2.40 B	27.04%
IDXX	39.73	27.96	70.38%	0.00%	$43.51 B	24.63%
RMD	18.74	4.39	23.41%	1.22%	$28.48 B	27.44%
HCA	12.70	-28.97	-228.14%	0.78%	$86.27 B	8.89%
DHR	33.74	2.57	7.61%	0.54%	$135.09 B	15.95%
SYK	37.64	5.47	14.52%	1.05%	$125.61 B	13.21%
PHG	22.19	1.90	8.56%	3.85%	$25.07 B	5.50%
COHR	117.65	5.01	4.26%	0.00%	$55.16 B	7.10%
INMD	11.06	1.46	13.18%	0.00%	$963.90 M	23.27%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SLP Historical Dividends

current DY: 0.00%

5-year average DY: 0.54%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	07/26/2024	08/05/2024	0.06000000
Dividends	04/25/2024	05/06/2024	0.06000000
Dividends	01/25/2024	02/05/2024	0.06000000
Dividends	10/26/2023	11/06/2023	0.06000000
Dividends	07/27/2023	08/07/2023	0.06000000
Dividends	04/20/2023	05/01/2023	0.06000000
Dividends	01/26/2023	02/06/2023	0.06000000
Dividends	10/27/2022	11/07/2022	0.06000000
Dividends	07/21/2022	08/01/2022	0.06000000
Dividends	04/21/2022	05/02/2022	0.06000000
Dividends	01/27/2022	02/07/2022	0.06000000
Dividends	10/21/2021	11/01/2021	0.06000000
Dividends	07/22/2021	08/02/2021	0.06000000
Dividends	04/22/2021	05/03/2021	0.06000000
Dividends	01/21/2021	02/01/2021	0.06000000
Dividends	10/22/2020	11/02/2020	0.06000000
Dividends	07/23/2020	08/03/2020	0.06000000
Dividends	04/22/2020	05/01/2020	0.06000000
Dividends	01/23/2020	02/03/2020	0.06000000
Dividends	10/23/2019	11/01/2019	0.06000000
Dividends	07/23/2019	08/01/2019	0.06000000
Dividends	04/22/2019	05/01/2019	0.06000000
Dividends	01/23/2019	02/01/2019	0.06000000
Dividends	10/30/2018	11/08/2018	0.06000000
Dividends	07/24/2018	08/02/2018	0.06000000
Dividends	04/23/2018	05/02/2018	0.06000000
Dividends	01/24/2018	02/02/2018	0.06000000
Dividends	11/09/2017	11/20/2017	0.06000000
Dividends	07/26/2017	08/04/2017	0.05000000
Dividends	05/04/2017	05/15/2017	0.05000000
Dividends	01/26/2017	02/06/2017	0.05000000
Dividends	11/08/2016	11/17/2016	0.05000000
Dividends	08/09/2016	08/18/2016	0.05000000
Dividends	04/28/2016	05/09/2016	0.05000000
Dividends	01/27/2016	02/05/2016	0.05000000
Dividends	11/05/2015	11/16/2015	0.05000000
Dividends	07/21/2015	07/30/2015	0.05000000
Dividends	05/07/2015	05/18/2015	0.05000000
Dividends	01/22/2015	02/02/2015	0.05000000
Dividends	11/05/2014	11/14/2014	0.05000000
Dividends	07/31/2014	08/11/2014	0.05000000
Dividends	05/07/2014	05/16/2014	0.05000000
Dividends	02/13/2014	02/24/2014	0.05000000
Dividends	11/06/2013	11/15/2013	0.04000000
Dividends	08/08/2013	08/15/2013	0.03000000
Dividends	05/03/2013	05/10/2013	0.03000000
Dividends	12/20/2012	12/28/2012	0.14000000
Dividends	11/06/2012	11/13/2012	0.05000000
Dividends	08/03/2012	08/10/2012	0.05000000
Dividends	04/25/2012	05/08/2012	0.05000000
Dividends	02/17/2012	03/01/2012	0.05000000

ABOUT Simulations Plus

Simulations Plus Inc.

Average Investor10 user rating

4.0 (2 people)

United States

30 years

Founded: 1996

1997

Time since IPO - 29 years

137

Employees

Simulations Plus Inc. (United States) is listed on the Nasdaq and has a market capitalization of $366.80 million, with shareholders equity totaling $139.03 million.

The company employs approximately 137 people and operates in the Health sector, within the Health Technology industry.

Over the past 12 months, Simulations Plus Inc. reported $82.06 million in revenue, generating net income of $8.12 million.

Key financial metrics include a P/E ratio of 45.17, a price-to-book (P/B) ratio of 2.64, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SLP.

Market cap

$366.80 million

Net worth

$139.03 million

$139,030,000.00

Assets

$152.98 million

$152,980,000.00

Total Shares Outstanding

20.00 million

20,000,000

Average Daily Trading Volume

$486.31 Thousand

$486,311.08

Sector

Health

Industry

Health Technology

SLP

SLP revenue and profits

Financial Results SLP

DRAG THE FRAME TO SEE MORE DATA

SLP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$106.93 83,70% (12M)

P/E

46.73

2.47%

ROE

3.78%

P/BV

1.76

CI - Cigna

$292.00 1,25% (12M)

P/E

11.72

2.13%

ROE

15.39%

P/BV

1.80

CNC - Centene

$64.13 125,89% (12M)

P/E

-4.85

0.00%

ROE

-29.93%

P/BV

1.45

HUM - Humana

$384.26 63,80% (12M)

P/E

41.90

0.67%

ROE

6.06%

P/BV

2.54

SNY - Sanofi

$44.31 --8,57% (12M)

P/E

7.10

4.07%

ROE

17.79%

P/BV

1.26

LLY - Eli Lilly

$1,198.69 49,60% (12M)

P/E

42.55

0.54%

ROE

81.02%

P/BV

34.48

HCA - HCA Healthcare

$389.58 17,30% (12M)

P/E

12.70

0.78%

ROE

-228.14%

P/BV

-28.97

NVS - Novartis

$156.65 35,68% (12M)

P/E

23.21

2.00%

ROE

30.41%

P/BV

7.06